Home > Insider Trading > Filing (0001415889-21-003550)

Filing Details

Accession Number:: 0001415889-21-003550
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-07-07 20:07:44
Reporting Period:: 2021-07-02

Accepted Time:: 2021-07-07 20:07:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1711968	Leonard Steven Chapman	C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753	Ceo And President	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-07-02	3,125	$0.00	77,755	No	4	M	Direct
Common Stock	Acquisiton	2021-07-02	9,375	$0.00	87,130	No	4	M	Direct
Common Stock	Disposition	2021-07-06	1,558	$118.59	85,572	No	4	S	Direct
Common Stock	Acquisiton	2021-07-06	2,404	$9.29	87,976	No	4	M	Direct
Common Stock	Acquisiton	2021-07-06	2,370	$13.01	90,346	No	4	M	Direct
Common Stock	Acquisiton	2021-07-06	8,203	$13.01	98,549	No	4	M	Direct
Common Stock	Acquisiton	2021-07-06	2,370	$20.27	100,919	No	4	M	Direct
Common Stock	Acquisiton	2021-07-06	4,922	$25.46	105,841	No	4	M	Direct
Common Stock	Acquisiton	2021-07-06	27	$10.73	105,868	No	4	M	Direct
Common Stock	Disposition	2021-07-06	6,045	$116.43	99,823	No	4	S	Direct
Common Stock	Disposition	2021-07-06	13,543	$117.13	86,280	No	4	S	Direct
Common Stock	Disposition	2021-07-06	708	$118.37	85,572	No	4	S	Direct
Common Stock	Disposition	2021-07-06	2,835	$116.59	82,737	No	4	S	Direct
Common Stock	Disposition	2021-07-06	3,126	$117.24	79,611	No	4	S	Direct
Common Stock	Disposition	2021-07-06	17	$118.59	79,594	No	4	S	Direct
Common Stock	Disposition	2021-07-07	4,633	$117.98	74,961	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2021-07-02	3,125	$0.00	3,125	$0.00
Common Stock	Restricted Stock Unit	Disposition	2021-07-02	9,375	$0.00	9,375	$0.00
Common Stock	Stock Option (right to buy)	Disposition	2021-07-06	2,404	$0.00	2,404	$9.29
Common Stock	Stock Option (right to buy)	Disposition	2021-07-06	2,370	$0.00	2,370	$13.01
Common Stock	Stock Option (right to buy)	Disposition	2021-07-06	8,203	$0.00	8,203	$13.01
Common Stock	Stock Option (right to buy)	Disposition	2021-07-06	2,370	$0.00	2,370	$20.27
Common Stock	Stock Option (right to buy)	Disposition	2021-07-06	4,922	$0.00	4,922	$25.46
Common Stock	Stock Option (right to buy)	Disposition	2021-07-06	27	$0.00	27	$10.73

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
18,750		No	4	M	Direct
9,375		No	4	M	Direct
31,937	2028-03-08	No	4	M	Direct
41,901	2029-01-10	No	4	M	Direct
46,484	2029-01-10	No	4	M	Direct
48,151	2029-04-11	No	4	M	Direct
27,890	2030-03-26	No	4	M	Direct
50	2027-07-13	No	4	M	Direct

Footnotes

Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") starting January 2, 2020.
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Represents the partial vesting and settlement of RSUs starting October 1, 2020.
The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs in compliance with Rule 10b5-1.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021, as amended on May 14, 2021
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.75 to $116.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.76 to $117.6150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.82 to $118.59 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.91 to $116.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.97 to $117.57 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The RSUs vest over four years. 25% of the RSUs vested on January 2, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.
On March 27, 2020, the Reporting Person was granted a RSU, which vests in three tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Issuer's stock price. On July 2, 2021, the Issuer's Board of Directors determined that the milestone for the second tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
This option vested and became exercisable upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of March 9, 2021, the criteria was satisfied with respect to 31,250 additional shares.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of June 3, 2021, the Company's Board of Director determined the performance criteria had been met with respect to 18,750 additional shares.
The option shares are fully vested and may be exercised at any time.